Statements (61)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:bfsLayer |
3
|
gptkbp:bfsParent |
gptkb:healthcare_organization
|
gptkbp:affects |
B cells
|
gptkbp:associated_with |
EBV infection
|
gptkbp:caused_by |
chromosomal translocation
|
gptkbp:clinical_trial |
targeted therapies
ongoing research new therapies may involve the abdomen may involve the central nervous system often presents with jaw lesions rapid tumor growth |
gptkbp:discovered_by |
1940s
|
gptkbp:end_of_life |
varies by subtype
improved with early treatment generally favorable with aggressive treatment |
gptkbp:first_described_by |
Dorothy Burkitt
|
gptkbp:genetic_diversity |
BC L2 gene
BC L6 gene MYC gene |
https://www.w3.org/2000/01/rdf-schema#label |
Burkitt lymphoma
|
gptkbp:is_often_used_in |
gptkb:Person
|
gptkbp:named_after |
Dr. Denis Burkitt
|
gptkbp:occurs_in |
higher in males
increased in certain regions |
gptkbp:origin |
gptkb:Africa
gptkb:New_Guinea |
gptkbp:research_focus |
environmental factors
genetic factors viral factors |
gptkbp:risk_factor |
malaria
immunosuppression HIV infection |
gptkbp:social_responsibility |
blood tests
imaging studies biopsy highly aggressive rare in developed countries associated with endemic malaria can be curable more common in equatorial Africa |
gptkbp:symptoms |
abdominal pain
fever night sweats swollen lymph nodes |
gptkbp:treatment |
gptkb:vaccine
supportive care radiation therapy chemotherapy stem cell transplant depends on stage depends on age antiviral therapy depends on overall health CODOX-M regimen R-CHOP regimen high-dose methotrexate |
gptkbp:type_of |
endemic Burkitt lymphoma
immunodeficiency-associated Burkitt lymphoma sporadic Burkitt lymphoma |